O&D-001 Injection

· O&D BioTech Group CO., Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for O&D-001 Injection, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]